Michael J. Blaha

Nationally representative data applying the PREVENT-ASCVD risk equations recommended by the 2026 #Dyslipidemia guideline indicate that approximately one-quarter of US adults aged 40-79 years are reclassified to different #cardiovascular risk categories compared with the prior pooled cohort equations (#PCEs). ja.ma/4yC8jXw

Is there a role for measuring coronary artery calcium progression in 2026? sciencedirect.com/science/articl… @MichaelJBlaha @OmarDzaye @AJPCardio

#Perspective: CAC scanning remains the preferred imaging tool for cardiovascular risk stratification in most asymptomatic patients. CCTA should be reserved for select high-risk populations. ahajrnls.org/49OWHpa

The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardio & Mortality Outcomes sciencedirect.com/science/articl… led by @JackieYaoMD @MichaelJBlaha @ZeinaDardari & their all-star team #🥍🐦🫀🏏🏊🏼‍♀️⛳️⚽️🎾

Incidence & Risk Factors for Aortic Dissection in a Community-Based Cohorts... sciencedirect.com/science/articl… led by John Erhabor @ZeinaDardari @MichaelJBlaha @seamuswhelton @RonBlankstein #🥍🐦🫀🏏🏊🏼‍♀️🎾🏀⛳️

Congrats @DanielMHuck on leading largest & longest F/U @MassGenBrigham #CCTA registry #JACCIMG paper. Motivated by Chest Pain Guideline, we evaluated yield and prognostic implications of CCTA by age, showing value in both younger + older populations 👉shorturl.at/YPRmn

@KSharmaMD @JoannaMeliaMD @JustinMDunn @ngilotraMD @soupvector @BTGaribaldi @hopkinsheart @rblument1 @SethShayMartin Wish I could have made it, but we had a Senior Prom and a Sweet 16 party for our oldest daughters this weekend. Great pics that bring back great memories!

Incredible celebration of the 50th Anniversary of the Osler Internal Medicine Residency Firms this weekend! Amazing symposium on the history and future of the Firm system - from the first Assistant Chiefs of Service, former Dept Chairs, program directors, and the most hearwarming reunion dinner with decades of #legends of the O together. So much gratitude to have trained, taught, and grown in this program - one like no other. @OslerAlumni @ChidaNatasha @NadiaHanselMD Charlie Weiner @sanjayvdesai #barkerfirm #thayerACS #bestofthebest @hopkins #Firmsat50 #oslerfirms

@shreyamehta876 @Steph_Achenbach @ArthurShiyovich @MichaelJBlaha @rblument1 @OKhaliqueMD @EricWillMD @RCardoso_MD @BudoffMd @lesleejshaw @DLBHATTMD Thanks @shreyamehta876. Many #BraunwaldCCT chapters relevant for prevention, but top 2 are: Chapter 3 on Coronary Artery Calcium (@JelaniGrantMD @rblument1 @MichaelJBlaha @khurramn1 ) Chapter 4 on CCTA for Primary Prevention (David Newby and @BudoffMd )

My 2 fave Companion Texts to Braunwald’s 🫀Disease. It was a high honor to work with the real GOAT of 🫀, Dr. Eugene Braunwald on this textbook along with co-editors ⁦@DrNathanWong⁩ & Dr. Joanne Foody. Also proud to co-author a Chapter on ⁦@RonBlankstein⁩ text!

Much gratitude to all the contributing authors -- all of whom are top leaders in the field of cardiac CT

Congrats to @DrMichaelShapir on this great honor. Dr. Shapiro has done a marvelous job as President of ASPC and was a key member of the writing group of the practice-changing 2026 ACC/AHA/Multisociety Dyslipidemia Guideline. Congratulations, Michael on the Arthur Agatston award!

#WBW Great Proclamation by Gov. William Donald Schaefer 36 yrs ago. The ⁦@CiccaroneCenter⁩ was conceived of by friends & former players of ⁦Lacrosse HOFer Henry Ciccarone. We are now entering our 37th year! #🐦🥍🫀⁦⁦@LacrosseNetwork⁩ ⁦@HopkinsMedicine⁩

Body Mass Index, Waist-to-Height Ratio, & Risks of Premature 🫀disease ... sciencedirect.com/science/articl… led by @JackieYaoMD @priyaumapathi @JR_Goldenberg @KSharmaMD & head Coach @MichaelJBlaha @AJPCardio @CiccaroneCenter @hopkinsheart #🥍🐦🫀🏏⛳️🎾⚽️⚾️ @khurramn1

So much fun to welcome Dr. David Thiemann back to Hurd Hall for ⁦@hopkinsheart⁩ Grand Rounds. #OslerPride ⁦@cingolani_oscar⁩

US Trends in Prescribing Nonstatin Lipid-Lowering Therapy, 2019-2024 jamanetwork.com/journals/jamac…

Just out in @JAMACardio our research letter shows nonstatin lipid-lowering prescriptions doubled from 2019–2024, yet still lag behind statins 11:1, with cardiologists prescribing up to 20x more than PCPs,highlighting a major gap in high-risk ASCVD care. @CiccaroneCenter #CardioX

The LPA gene has an IL-6 response element, meaning when IL-6 levels go up and reach the liver, more Lp(a) is made. There are drugs in development for both lp(a) and IL-6, what does this mean for interpreting results? Here is a succinct summary of the salient issues: academic.oup.com/eurjpc/advance….

🚨 New press release on orforglipron's ACHIEVE-4 cardiovascular safety profile 💊 Orforglipron(Foundayo), the recently approved oral GLP-1 for obesity, here studied in adults with type 2 diabetes vs insulin glargine ⬇️ 24% 3-point MACE (heart attack, stroke, cardiovascular death) ⬇️ 16% 4-point MACE (heart attack, stroke, cardiovascular death, hospitalization with chest pain) ⬇️ 57% all-cause death investor.lilly.com/news-releases/…

Beyond the sum of its parts: reassessing cardiovascular screening through the full DANCAVAS lens academic.oup.com/eurheartj/arti… by @khurramn1 @MichaelJBlaha & Safi Khan @CiccaroneCenter @hopkinsheart @HMHCardioFellow @MethodistHosp @DrMarthaGulati @WilliamZoghbi #🥍🐦🫀🏏⛳️⚾️🎾🏈

Aortic valve calcium (AVC) predicts long-term risk of moderate–severe aortic stenosis equally in females & males. Despite lower AVC levels in females, its prognostic value remains consistent: AVC is a key risk marker for both men & women @seamuswhelton ahajrnls.org/4t0LYPV